Global Medical REIT Inc.

GMRE | NYSE

Price Alert Chart Builder DCF Calculator

$35.74

-$0.45 (-1.24%)

Mar 06, 2026, 09:30 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $478.13M

Enterprise Value $467.47M

Beta 1.20

Average Volume N/A

Shares Outstanding (Diluted) 13.24M

Shares Change YoY 394.76%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 3.0%

1Y CAGR (ann.) -6.2%

5Y CAGR (ann.) -4.3%

All-Time CAGR -13.8%

Valuation

PE Ratio 9.58

Forward PE 444.64

PEG Ratio -2.09

Forward PEG 0.29

PS Ratio 3.11

Forward PS 3.00

PB Ratio 0.73

P/FCF Ratio 11.80

P/Adj. FCF Ratio 13.55

P/OCF Ratio 6.30

EV/Sales 3.04

EV/EBIT -114.74

EV/EBITDA 17.70

EV/FCF 11.54

Earnings Yield 10.4%

FCF Yield 8.5%

Adj. FCF Yield 7.4%

Financial Health

Net Cash $10.66M

Total Debt $0

Cash & Short-Term Investments $10.66M

Total Assets $1.37B

Current Ratio 0.00

Quick Ratio 0.00

Debt / Equity Ratio 0.00

Debt / EBITDA 0.00

Debt / FCF 0.00

OCF / Debt N/A

Interest Coverage 0.35

Altman Z-Score 0.22

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 11.3%

Operating Profit Margin 8.1%

EBITDA Margin 17.2%

Net Profit Margin 30.1%

FCF Margin 26.4%

Adj. FCF Margin 23.0%

SBC / Revenue 3.4%

SBC Impact (per share) -12.9%

Returns

Return on Assets 3.4%

Return on Equity 8.6%

Return on Invested Capital 7.8%

Return on Capital Employed 0.9%

Return on Tangible Assets 3.8%

Historical Growth (CAGR)

Revenue CAGR 3Y 2.1%

Revenue CAGR 5Y 7.8%

Revenue CAGR 10Y 43.2%

EPS CAGR 3Y -23.9%

EPS CAGR 5Y -29.3%

EPS CAGR 10Y 5.3%

FCF CAGR 3Y 47.1%

FCF CAGR 5Y 218.6%

FCF CAGR 10Y 29.3%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 22

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y 2.2%

Earnings Date Feb 24, 2026

EPS Estimate (next Q) $0.07

EPS Growth Est (next Q) -87.5%

Revenue Est (next Q) $37.44M

Revenue Growth Est (next Q) 7.1%

Fair Value Estimates

Graham Number $65.86

Graham Upside 84.3%

Lynch Fair Value $18.65

Lynch Upside -47.8%

Price Target $20.92

Price Target Upside -41.5%

Cash Flow

Operating Cash Flow $75.11M

Free Cash Flow $40.52M

Adj. Free Cash Flow $35.3M

FCF Per Share $3.06

OCF Per Share $5.67

OCF/S Ratio 48.9%

Income Statement

Revenue $153.54M

Gross Profit $17.33M

Operating Income $12.47M

EBITDA $26.41M

Net Income $46.21M

EPS (Diluted) $3.73

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A

Dividends

Annual Dividend $1.50

Dividend Yield 4.20%

Payout Ratio 40.2%

FCF Payout Ratio 111.2%

Adj. FCF Payout Ratio 127.7%

Dividend Growth (YoY) -64.3%

Pay Frequency Quarterly

Ex-Dividend Date Dec 18, 2025